WallStSmart

Park Ha Biological Technology Co., Ltd. (BYAH)vsThe Coca-Cola Company (KO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Coca-Cola Company generates 1951896% more annual revenue ($49.28B vs $2.52M). KO leads profitability with a 27.8% profit margin vs 0.0%. KO earns a higher WallStSmart Score of 65/100 (B-).

BYAH

Avoid

30

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 5.0Quality: 6.0
Piotroski: 3/9Altman Z: -16.66

KO

Strong Buy

65

out of 100

Grade: B-

Growth: 6.0Profit: 9.5Value: 3.3Quality: 6.0
Piotroski: 6/9Altman Z: 2.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BYAH.

KOSignificantly Overvalued (-29.0%)

Margin of Safety

-29.0%

Fair Value

$61.61

Current Price

$79.48

$17.87 premium

UndervaluedFair: $61.61Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BYAH2 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

KO5 strengths · Avg: 9.4/10
Market CapQuality
$338.86B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
40.7%10/10

Every $100 of equity generates 41 in profit

Operating MarginProfitability
35.1%10/10

Strong operational efficiency at 35.1%

Profit MarginProfitability
27.8%9/10

Keeps 28 of every $100 in revenue as profit

Free Cash FlowQuality
$1.75B8/10

Generating 1.8B in free cash flow

Areas to Watch

BYAH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.77M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

KO3 concerns · Avg: 3.0/10
Price/BookValuation
10.2x4/10

Trading at 10.2x book value

Debt/EquityHealth
1.303/10

Elevated debt levels

PEG RatioValuation
4.022/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : BYAH

The strongest argument for BYAH centers on Price/Book, Debt/Equity.

Bull Case : KO

The strongest argument for KO centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 27.8% and operating margin at 35.1%. Revenue growth of 12.1% demonstrates continued momentum.

Bear Case : BYAH

The primary concerns for BYAH are EPS Growth, Market Cap, Profit Margin.

Bear Case : KO

The primary concerns for KO are Price/Book, Debt/Equity, PEG Ratio.

Key Dynamics to Monitor

BYAH profiles as a value stock while KO is a mature play — different risk/reward profiles.

KO is growing revenue faster at 12.1% — sustainability is the question.

KO generates stronger free cash flow (1.8B), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KO scores higher overall (65/100 vs 30/100), backed by strong 27.8% margins and 12.1% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Park Ha Biological Technology Co., Ltd.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · China

Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company is headquartered in Wuxi, the People's Republic of China.

The Coca-Cola Company

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

The Coca-Cola Company is an American multinational beverage corporation incorporated under Delaware's General Corporation Law and headquartered in Atlanta, Georgia. The Coca-Cola Company has interests in the manufacturing, retailing, and marketing of nonalcoholic beverage concentrates and syrups.

Visit Website →

Want to dig deeper into these stocks?